Found 0 matching trials
68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma NA This clinical study investigates the use of a new imaging technique called ...
Show More Location
Centre Hospitalier Universitaire Vaudois
Learn More & Join Trial
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer PHASE2 The goal of this clinical trial is to investigate the use of the tracer \[6...
Show More Location
Herlev Universityhospital
Learn More & Join Trial
Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer PHASE2 This is a phase II study, preceded by a safety run-in, with two independent...
Show More Status
Active Not Recruiting
Learn More & Join Trial
68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors PHASE2 Phase II, open label, single arm, single center, prospective diagnostic tri...
Show More Location
IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l.
Learn More & Join Trial
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma NA The aim of this study is to compare the diagnostic performance of 68Ga-FAPI...
Show More Location
National Centre of Oncology
Learn More & Join Trial
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) NA Prospective multicenter study evaluating the prediction of histological res...
Show More Location
Hôpital Privé d'Antony
Learn More & Join Trial
Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis PHASE2 Transthyretin cardiac amyloidosis (ATTR-CM) is an infiltrative cardiomyopat...
Show More Learn More & Join Trial